Category: Press Release - Page 188 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

Post published:October 30, 2020
Post category:Press Release

Read more about the article MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™

MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™

Post published:October 30, 2020
Post category:Press Release

Read more about the article Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials

Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials

Post published:October 29, 2020
Post category:Press Release

Read more about the article Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment

Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment

Post published:October 29, 2020
Post category:Press Release

Read more about the article Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor

Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor

Post published:October 29, 2020
Post category:Press Release

Read more about the article Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Post published:October 29, 2020
Post category:Press Release

Read more about the article Champignon Brands Provides Update on Continuous Disclosure Review

Champignon Brands Provides Update on Continuous Disclosure Review

Post published:October 29, 2020
Post category:Press Release

Read more about the article Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

Post published:October 28, 2020
Post category:Press Release

Read more about the article Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain

Post published:October 28, 2020
Post category:Press Release

Read more about the article MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

Post published:October 27, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.